Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 13, Issue 5, Pages 547-555Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.ejhg.5201374
Keywords
skeletal dysplasia; cartilage oligomeric matrix protein; gene mutation; molecular diagnosis
Funding
- Wellcome Trust [071161] Funding Source: Medline
Ask authors/readers for more resources
The skeletal dysplasias are a clinically and genetically heterogeneous group of conditions affecting the development of the osseous skeleton and fall into the category of rare genetic diseases in which the diagnosis can be difficult for the nonexpert. Two such diseases are pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED), which result in varying degrees of short stature, joint pain and stiffness and often resulting in early onset osteoarthritis. PSACH and some forms of MED result from mutations in the cartilage oligomeric matrix protein ( COMP) gene and to aid the clinical diagnosis and counselling of patients with a suspected diagnosis of PSACH or MED, we developed an efficient and accurate molecular diagnostic service for the COMP gene. In a 36-month period, 100 families were screened for a mutation in COMP and we identified disease-causing mutations in 78% of PSACH families and 36% of MED families. Furthermore, in several of these families, the identification of a disease-causing mutation provided information that was immediately used to direct reproductive decision-making.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available